Anil P. Ranganath - Aug 1, 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
Senior Vice President, General Counsel and Secretary
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol
TMDX
Transactions as of
Aug 1, 2023
Transactions value $
$0
Form type
4
Date filed
8/4/2023, 05:16 PM
Previous filing
Jun 7, 2023
Next filing
Aug 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Award $0 +9.51K $0.00 9.51K Aug 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Award $0 +14.7K $0.00 14.7K Aug 1, 2023 Common Stock 14.7K $93.88 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 9,512 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 The Option vests as to 25% on August 1, 2024 and as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service.

Remarks:

Senior Vice President, General Counsel and Secretary